Publications & Research

CT screening catches small cell lung cancers earlier

In one of the largest studies yet to focus on a rare type of lung cancer, radiologists from Columbia University in New York City found that CT screening and treatment when indicated may spare the lives of patients with small cell lung cancer (SCLC).

CT screening corresponded to significantly lower disease stage at diagnosis. In fact, most of the handful of early-stage SCLC patients who underwent resection are still alive five years later, the researchers found.

The screening results compared favorably to data from patients who received standard care, in which CT was used for staging rather than screening of small cell lung cancers. The comparison data came from a large 2007 study by Shepherd et al from the International Association for the Study of Lung Cancer (IASLC) database.

Click here to view the full article.



  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More


  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More